1-800-729-1232

tepezza

Understanding and Managing Adverse Events in Patients Treated with Tepezza

Product Liability / November 21, 2023 / 4 minutes of reading / By / , , , , , , , , , ,

Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown remarkable efficacy in reducing eye bulging and double vision. However, like any medication, it is important to be aware of the potential adverse events associated …

Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More »

Tepezza: FDA Adds Hearing Loss and Impairment Warnings to Drug Label

Product Liability / November 21, 2023 / 4 minutes of reading / By / , , , , , , , , ,

The U.S. Food and Drug Administration (FDA) recently took a significant step toward enhancing patient safety by updating the warning label for Horizon Pharmaceutical’s drug, Tepezza. Tepezza is a medication used to treat thyroid eye disease (TED), a chronic condition associated with eye inflammation and related vision problems. This Tepezza warning label update includes important …

Tepezza: FDA Adds Hearing Loss and Impairment Warnings to Drug Label Read More »

Tepezza and the Alleged Hearing Loss Risk: A Deep Dive into the Controversial Drug

Product Liability / November 21, 2023 / 4 minutes of reading / By / , , , ,

Tepezza, a groundbreaking drug manufactured by Horizon Therapeutics, has been heralded as a revolutionary treatment for thyroid eye disease (TED). However, recent allegations of hearing loss risks associated with the medication have raised concerns among consumers, healthcare professionals, and regulators. This article examines these claims, along with the effectiveness of Tepezza in treating thyroid eye …

Tepezza and the Alleged Hearing Loss Risk: A Deep Dive into the Controversial Drug Read More »

Tepezza

Did You Have Hearing Problems After Tepezza® Injections? A study shows 16% of patients taking Horizon Therapeutics’ thyroid eye disease drug Tepezza may experience long-term otologic symptoms like hearing loss and/or tinnitus, which can persist even after the drug treatment is discontinued. Start My Tepezza Hearing Loss Lawsuit Claim Now Please enable JavaScript in your …

Tepezza Read More »

Scroll to Top